Foreign-invested pharmaceutical firms are turning to outsourcing

Influenced by subsequent reductions in reimbursed drug prices and expected business downturn until the first half of next year, foreign-invested pharmaceutical firms are turning their eyes to the outsourcing as a way of seeking their sustained sales growth.

Pharmaceutical business source say that a number of leading foreign-invested pharmaceutical firms are actively tapping the possibility ...